SP-MHCI-0689-2

Human Protein SSX2 103-111, RLQGISPKI

US$169.00

In stock

Description

About Human Protein SSX2 103-111, RLQGISPKI

The Human Protein SSX2 Peptide (IEDB: 138807) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Protein SSX2 Peptide, H-RLQGISPKI-OH (Uniprot: Q16385 aa: 103-111) from JPT is produced under strict quality control and quality management.

Human Protein SSX2 103-111, RLQGISPKI - Specifications

  • Peptide sequence: H-RLQGISPKI-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Prostate cancer, Hepatocellular carcinoma
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Protein SSX2 103-111, RLQGISPKI

References:
Read References with JPT’s Antigen Peptides
Human Protein SSX2 103-111, RLQGISPKI has been described in:
Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor., Immunol Lett, 2009 (PMID: 19524620)
Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells., J Immunother, 2011 (PMID: 21904219)

Documentation

Documentation for Human Protein SSX2 103-111, RLQGISPKI

Properties

Properties of Human Protein SSX2 103-111, RLQGISPKI

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Hepatocellular carcinoma, Prostate cancer
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Protein SSX2 103-111, RLQGISPKI

Information Values
Sequence: H-RLQGISPKI-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote